Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $927.05 billion, total revenue of $177.12 billion and a weighted average PE ratio of 47.71.
Market Cap
927.05B
Revenue
177.12B
Profits
19.43B
PE Ratio
47.71
Profit Margin
10.97%
Dividend Yield
0.18%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 259.44B | 0.11% | 1,837,421 | 47.35B |
| 2 | DHR | Danaher Corporation | 163.94B | 0.37% | 3,359,510 | 25.61B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 55.48B | 0.89% | 392,153 | 4.66B |
| 4 | A | Agilent Technologies, Inc. | 49.04B | 0.55% | 1,415,208 | 7.37B |
| 5 | NTRA | Natera, Inc. | 46.27B | -1.19% | 1,690,788 | 2.91B |
| 6 | WAT | Waters Corporation | 45.24B | -0.42% | 521,853 | 5.61B |
| 7 | IQV | IQVIA Holdings Inc. | 43.69B | -2.21% | 1,986,079 | 17.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 34.59B | 0.46% | 142,677 | 4.20B |
| 9 | ILMN | Illumina, Inc. | 31.30B | -1.21% | 1,229,533 | 4.54B |
| 10 | LH | Labcorp Holdings Inc. | 30.08B | -0.49% | 488,973 | 14.59B |
| 11 | DGX | Quest Diagnostics Incorporated | 28.56B | -0.02% | 649,384 | 11.84B |
| 12 | GH | Guardant Health, Inc. | 20.52B | -2.04% | 1,293,355 | 1.28B |
| 13 | MEDP | Medpace Holdings, Inc. | 18.29B | -0.44% | 105,444 | 2.84B |
| 14 | RVTY | Revvity, Inc. | 17.24B | -1.67% | 1,306,669 | 2.94B |
| 15 | CRL | Charles River Laboratories International, Inc. | 16.19B | -0.83% | 838,318 | 3.98B |
| 16 | ICLR | ICON Public Limited Company | 14.58B | -2.92% | 966,540 | 8.23B |
| 17 | QGEN | Qiagen N.V. | 10.30B | -0.42% | 1,642,137 | 2.12B |
| 18 | RDNT | RadNet, Inc. | 6.02B | 0.50% | 476,239 | 2.38B |
| 19 | GRAL | GRAIL, Inc. | 5.21B | -4.50% | 359,739 | 166.60M |
| 20 | BLLN | BillionToOne, Inc. | 5.02B | -5.09% | 672,185 | 436.87M |
| 21 | SHC | Sotera Health Company | 4.74B | 1.90% | 2,647,528 | 1.23B |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.70B | -1.49% | 2,063,762 | 298.01M |
| 23 | CDNA | CareDx, Inc. | 4.09B | -2.42% | 716,919 | 497.40M |
| 24 | NEO | NeoGenomics, Inc. | 2.07B | -3.14% | 2,217,573 | 787.75M |
| 25 | VCYT | Veracyte, Inc. | 1.96B | -1.22% | 2,029,304 | 581.78M |
| 26 | PSNL | Personalis, Inc. | 1.70B | -0.95% | 2,803,801 | 80.77M |
| 27 | WGS | GeneDx Holdings Corp. | 1.57B | 0.96% | 1,123,560 | 460.78M |
| 28 | OPK | OPKO Health, Inc. | 1.25B | 0.60% | 2,137,837 | 654.10M |
| 29 | FRNM | Freenome, Inc. | 1.12B | -1.89% | 615,402 | 217.86M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.04B | -2.06% | 347,750 | 377.13M |
| 31 | FLGT | Fulgent Genetics, Inc. | 688.98M | -0.76% | 262,094 | 330.28M |
| 32 | MYGN | Myriad Genetics, Inc. | 542.92M | -0.35% | 1,051,779 | 803.60M |
| 33 | BNR | Burning Rock Biotech Limited | 140.16M | -0.30% | 455 | 73.70M |
| 34 | BDSX | Biodesix, Inc. | 109.55M | 0.92% | 386,397 | 105.21M |
| 35 | XGN | Exagen Inc. | 100.05M | -6.35% | 3,356,970 | 72.30M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 70.03M | -7.36% | 164,748 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 53.22M | 12.15% | 565,562 | 1.50M |
| 38 | PRPO | Precipio, Inc. | 39.62M | -4.82% | 14,708 | 27.76M |
| 39 | MDXH | MDxHealth SA | 13.75M | 2.93% | 2,003,705 | 114.01M |
| 40 | NDRA | ENDRA Life Sciences Inc. | 6.61M | -4.96% | 4,574 | - |
| 41 | XWEL | XWELL, Inc. | 4.54M | -5.42% | 63,798 | 28.28M |
| 42 | ADVB | Advanced Biomed Inc. | 4.18M | -23.56% | 198,271 | 127.64K |
| 43 | BIAF | bioAffinity Technologies, Inc. | 4.00M | -5.98% | 51,554 | 5.53M |
| 44 | ISPC | iSpecimen Inc. | 3.81M | -5.43% | 114,985 | 466.30K |